{
    "2021-03-17": [
        [
            {
                "time": "",
                "original_text": "兼并重组大势下，医药连锁行业迎巨变，健之佳胃口仅是“西南”？",
                "features": {
                    "keywords": [
                        "兼并重组",
                        "医药连锁",
                        "健之佳",
                        "西南"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "西南证券---医药行业2021年一季度业绩前瞻：CXO、器械、药店等有望延续高增长【行业研究】",
                "features": {
                    "keywords": [
                        "西南证券",
                        "医药行业",
                        "CXO",
                        "器械",
                        "药店",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}